Stephen Hanauer to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Stephen Hanauer has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.209
-
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2019 01; 17(1):139-147.
Score: 0.151
-
COLAL-PRED Alizyme. Curr Opin Investig Drugs. 2004 Nov; 5(11):1192-7.
Score: 0.058